Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife. 2013 Jul 16; 2:e00825.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.